NCT00835367View on ClinicalTrials.gov

Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

March 31, 2004

Study Completion Date

March 31, 2004

Conditions
Healthy
Interventions
DRUG

Amlodipine-benazepril 10 mg-20 mg capsules

1 x 10-20 mg

DRUG

Lotrel® 10 mg-20 mg capsule

1 x 10-20 mg

Trial Locations (2)

H2X 2H9

Anapharm Inc., Montreal

G1V 2K8

SFBC Anapharm, Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00835367 - Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fed Conditions | Biotech Hunter | Biotech Hunter